These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 9664234)
1. Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice. Tsunoda M; Sharma RP; Riley RT J Biochem Mol Toxicol; 1998; 12(5):281-9. PubMed ID: 9664234 [TBL] [Abstract][Full Text] [Related]
2. Toxicology and carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies). Natl Toxicol Program Tech Rep Ser; 2001 Dec; (496):1-352. PubMed ID: 11852482 [TBL] [Abstract][Full Text] [Related]
3. Subchronic toxic effects of Fusarium moniliforme and fumonisin B1 in rats and mice. Voss KA; Riley RT; Bacon CW; Chamberlain WJ; Norred WP Nat Toxins; 1996; 4(1):16-23. PubMed ID: 8680749 [TBL] [Abstract][Full Text] [Related]
4. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme. Schroeder JJ; Crane HM; Xia J; Liotta DC; Merrill AH J Biol Chem; 1994 Feb; 269(5):3475-81. PubMed ID: 8106389 [TBL] [Abstract][Full Text] [Related]
5. Mycotoxin-induced elevation of free sphingoid bases in precision-cut rat liver slices: specificity of the response and structure-activity relationships. Norred WP; Plattner RD; Dombrink-Kurtzman MA; Meredith FI; Riley RT Toxicol Appl Pharmacol; 1997 Nov; 147(1):63-70. PubMed ID: 9356308 [TBL] [Abstract][Full Text] [Related]
6. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Riley RT; Enongene E; Voss KA; Norred WP; Meredith FI; Sharma RP; Spitsbergen J; Williams DE; Carlson DB; Merrill AH Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):301-8. PubMed ID: 11359699 [TBL] [Abstract][Full Text] [Related]
7. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. Merrill AH; van Echten G; Wang E; Sandhoff K J Biol Chem; 1993 Dec; 268(36):27299-306. PubMed ID: 8262970 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1. Soriano JM; González L; Catalá AI Prog Lipid Res; 2005 Nov; 44(6):345-56. PubMed ID: 16266752 [TBL] [Abstract][Full Text] [Related]
9. Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: a new mechanism of nephrotoxicity. Riley RT; Hinton DM; Chamberlain WJ; Bacon CW; Wang E; Merrill AH; Voss KA J Nutr; 1994 Apr; 124(4):594-603. PubMed ID: 8145083 [TBL] [Abstract][Full Text] [Related]
10. Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs. Riley RT; An NH; Showker JL; Yoo HS; Norred WP; Chamberlain WJ; Wang E; Merrill AH; Motelin G; Beasley VR Toxicol Appl Pharmacol; 1993 Jan; 118(1):105-12. PubMed ID: 8430417 [TBL] [Abstract][Full Text] [Related]
11. In vivo effects of fumonisin B1-producing and fumonisin B1-nonproducing Fusarium moniliforme isolates are similar: fumonisins B2 and B3 cause hepato- and nephrotoxicity in rats. Voss KA; Plattner RD; Riley RT; Meredith FI; Norred WP Mycopathologia; 1998; 141(1):45-58. PubMed ID: 9725030 [TBL] [Abstract][Full Text] [Related]
12. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver. He Q; Suzuki H; Sharma N; Sharma RP Toxicol Sci; 2006 Dec; 94(2):388-97. PubMed ID: 16960033 [TBL] [Abstract][Full Text] [Related]
13. Demonstration of in-situ apoptosis in mouse liver and kidney after short-term repeated exposure to fumonisin B1. Sharma RP; Dugyala RR; Voss KA J Comp Pathol; 1997 Nov; 117(4):371-81. PubMed ID: 9502273 [TBL] [Abstract][Full Text] [Related]
14. Disruption of sphingolipid metabolism in small intestines, liver and kidney of mice dosed subcutaneously with fumonisin B(1). Enongene EN; Sharma RP; Bhandari N; Voss KA; Riley RT Food Chem Toxicol; 2000 Sep; 38(9):793-9. PubMed ID: 10930700 [TBL] [Abstract][Full Text] [Related]
15. Gender-related differences in subacute fumonisin B1 hepatotoxicity in BALB/c mice. Bhandari N; He Q; Sharma RP Toxicology; 2001 Aug; 165(2-3):195-204. PubMed ID: 11522378 [TBL] [Abstract][Full Text] [Related]
16. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins. Riley RT; Wang E; Schroeder JJ; Smith ER; Plattner RD; Abbas H; Yoo HS; Merrill AH Nat Toxins; 1996; 4(1):3-15. PubMed ID: 8680751 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of sphingolipid biosynthesis in rat primary hepatocyte cultures by fumonisin B1 and other structurally related compounds. van der Westhuizen L; Shephard GS; Snyman SD; Abel S; Swanevelder S; Gelderblom WC Food Chem Toxicol; 1998 Jun; 36(6):497-503. PubMed ID: 9674957 [TBL] [Abstract][Full Text] [Related]
18. Fumonisin contamination of food: progress in development of biomarkers to better assess human health risks. Turner PC; Nikiema P; Wild CP Mutat Res; 1999 Jul; 443(1-2):81-93. PubMed ID: 10415433 [TBL] [Abstract][Full Text] [Related]
19. Carcinogenicity and mechanism of action of fumonisin B1: a mycotoxin produced by Fusarium moniliforme (= F. verticillioides). Voss KA; Howard PC; Riley RT; Sharma RP; Bucci TJ; Lorentzen RJ Cancer Detect Prev; 2002; 26(1):1-9. PubMed ID: 12088196 [TBL] [Abstract][Full Text] [Related]
20. Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme. Wang E; Ross PF; Wilson TM; Riley RT; Merrill AH J Nutr; 1992 Aug; 122(8):1706-16. PubMed ID: 1640265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]